Edition:
United States

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

73.53EUR
10:11am EDT
Change (% chg)

€0.34 (+0.46%)
Prev Close
€73.19
Open
€73.46
Day's High
€73.61
Day's Low
€72.89
Volume
364,277
Avg. Vol
1,029,809
52-wk High
€77.45
52-wk Low
€60.00

FREG.DE

Chart for FREG.DE

About

Fresenius SE & Co KGaA is a health care company. It operates in the healthcare sector and offers products and services for dialysis, hospitals and outpatient medical care. It focuses on the hospital operations and offers engineering and services for hospitals and other health care facilities. The Company’s operating segments... (more)

Overall

Beta: 0.57
Market Cap(Mil.): €40,508.71
Shares Outstanding(Mil.): 553.47
Dividend: 0.62
Yield (%): 0.85

Financials

  FREG.DE Industry Sector
P/E (TTM): 25.83 32.67 29.98
EPS (TTM): 2.83 -- --
ROI: 9.28 5.67 13.08
ROE: 13.10 8.92 14.23

Fitch Rates Fresenius Finance Ireland Bonds at 'BBB-'; Affirms Fresenius at 'BBB-'

(The following statement was released by the rating agency) LONDON, March 23 (Fitch) Fitch Ratings has assigned Fresenius Finance Ireland PLC's (FFI) EUR2.6 billion guaranteed senior notes an instrument rating of 'BBB-'. It has also affirmed Fresenius Medical Care AG (FMC) & Co. KGaA and Fresenius SE & Co.KGaA's (FSE, together Fresenius) Long-Term Issuer Default Rating at 'BBB-'. The Outlook is Stable. A full list of rating actions is at the end of this commentary. KEY RATING DRIVERS Market

Mar 23 2017

BRIEF-Fresenius CEO says larger takeovers possible

* Says have looked at biosimilars and don't rule out becoming active in that area

Feb 22 2017

BRIEF-Fresenius FY 2016 sales up 5 pct at 29.1 billion euros

* FY sales 29.1 billion euros ($30.68 billion) (+5 pct, +6 pct in constant currency)

Feb 22 2017

UPDATE 3-New Nestle CEO ditches elusive sales target

* New CEO says not right time for big M&A (Adds fresh CEO, analyst comments, shares)

Feb 16 2017

BRIEF-Fresenius says Quironsalud to be consolidated as of Feb. 1

* Says Quironsalud will be consolidated as of February 1, 2017

Jan 31 2017

BRIEF-Fresenius SE to issue 500 mln eur convertible bonds

* Fresenius announces issuance of equity-neutral convertible bonds

Jan 19 2017

BRIEF-Fresenius SE places EUR2.6 bln in notes to fund Quirónsalud purchase

* Says places four tranches with volumes of 700 and 500 million

Jan 17 2017

BRIEF-Fresenius sees further growth prospect for Kabi unit

* CEO says still sees opportunities for Kabi to grow, both organically and via M&A

Oct 27 2016

More From Around the Web

Earnings vs. Estimates